Those projections of reduced spending were reflected in a survey released in December by data analytics firm Numerator that ...

GLP-1 RAs are associated with reduced type 2 diabetes mellitus (T2DM)-related dementia risk compared with metformin.

GLP-1 receptor agonists linked to lower medication use and reduced headaches, visual disturbances or blindness, and papilledema.

In this week’s Kern Cares, Dr. Hashimoto from BFMG joined host Kait Hill to unpack one of today’s most talked-about health ...

For older adults with diabetes, there is no evidence to suggest that the incidence of dementia differs for those using GLP-1 RAs vs DPP4is.

No difference in mortality risk seen for GLP-1 RA and SGLT2i users; significantly lower risk seen for GLP-1 RA vs DPP4i users.

From supplements to injectables to belly-fat blasting beverages, there are plenty of products that claim to speed weight loss ...

Indian pharmaceutical company, Cipla, aims to reach $1 billion in US sales by FY27, driven by upcoming product launches.

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...

New research reveals GLP-1 drugs like Ozempic may reduce stroke risk and improve recovery. At the 22nd Annual Meeting of the ...

PepsiCo, Inc. (NASDAQ:PEP) is one of the stocks that Jim Cramer recently commented on. During the episode, Cramer noted that ...